Large-scale testing (Phase 3)UnknownNCT04221152
What this trial is testing
A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )
Who this might be right for
Insulin Resistance - Type AInsulin Resistance - Type BLipoatrophic Diabetes Mellitus+1 more
Kobe University 8